Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score

Background Survival with left ventricular assist device (LVAD) therapy is dependent on appropriate patient selection. The HeartMate II risk score (HMRS) was recently derived and validated to predict 90-day mortality in clinical trial patients with continuous-flow LVADs. The aim of this study was to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of heart and lung transplantation 2014-07, Vol.33 (7), p.675-681
Hauptverfasser:	Thomas, Sunu S., MD, MSc, Nahumi, Nadav, BA, Han, Jason, BA, Lippel, Matthew, BA, Colombo, Paolo, MD, Yuzefpolskaya, Melana, MD, Takayama, Hiroo, MD, PhD, Naka, Yoshifumi, MD, PhD, Uriel, Nir, MD, Jorde, Ulrich P., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged continuous-flow left ventricular assist device Female heart failure Heart Failure - mortality Heart Failure - physiopathology Heart Failure - therapy Heart-Assist Devices Humans Kaplan-Meier Estimate Male mechanical circulatory support Middle Aged mortality Preoperative Period Prognosis Reproducibility of Results Retrospective Studies Risk Assessment - methods Risk Factors risk score Surgery Treatment Outcome Ventricular Dysfunction, Left - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!